Also trades as: CHIZF (OTC) · $vol 0M
0570.HK HKSE
China Traditional Chinese Medicine Holdings Co. Limited
1W: -2.4%
1M: -8.2%
3M: -14.0%
YTD: -40.0%
1Y: -45.1%
3Y: -63.0%
5Y: -72.7%
HK$1.19 ($0.15)
-0.04 (-3.25%)
Weekly Expected Move ±4.9%
HK$1
HK$1
HK$1
HK$1
HK$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$32.4B
-7.7% ▼
5Y CAGR: -0.4%
Total Liabilities
$8.9B
-19.7% ▼
5Y CAGR: -6.0%
Shareholders Equity
$20.5B
-3.4% ▼
5Y CAGR: +2.5%
Cash & Investments
$5.2B
-3.4% ▼
5Y CAGR: +0.5%
Total Debt
$2.5B
-37.9% ▼
5Y CAGR: -13.7%
Net Debt
-$1.6B
-1143.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.9B | $3.1B | $3.0B | $3.9B | $4.0B |
| Short-Term Investments | $1.2B | $605M | $673M | $1.5B | $1.1B |
| Cash & ST Investments | $4.1B | $3.5B | $3.7B | $5.3B | $5.2B |
| Net Receivables | $8.3B | $7.6B | $9.2B | $8.3B | $8.7B |
| Inventory | $5.0B | $6.0B | $6.0B | $4.8B | $3.7B |
| Other Current Assets | $677M | $698M | $845M | $154M | $3 |
| Total Current Assets | $18.2B | $18.0B | $19.8B | $18.8B | $17.7B |
| Property, Plant & Equip. | $8.0B | $8.0B | $8.0B | $7.7B | $7.2B |
| Goodwill & Intangibles | $9.7B | $9.3B | $8.9B | $8.1B | $7.0B |
| Long-Term Investments | -$1.2B | -$590M | $12M | $11M | $167M |
| Other Non-Current Assets | $1.5B | $695M | $353M | $367M | $13M |
| Total Non-Current Assets | $18.2B | $17.7B | $17.3B | $16.2B | $14.6B |
| Total Assets | $36.4B | $35.6B | $37.1B | $35.1B | $32.4B |
| — Liabilities — | |||||
| Accounts Payable | $1.9B | $1.9B | $2.7B | $2.2B | $2.2B |
| Short-Term Debt | $2.2B | $4.5B | $3.0B | $2.1B | $2.2B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $136M |
| Other Current Liabilities | $1.8B | $2.2B | $2.0B | $1.8B | $2.6B |
| Total Current Liabilities | $8.8B | $10.1B | $9.3B | $7.8B | $7.7B |
| Long-Term Debt | $2.8B | $466M | $2.1B | $1.8B | $208M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $5.0B | $2.6B | $3.8B | $3.3B | $1.2B |
| Total Liabilities | $13.7B | $12.7B | $13.1B | $11.1B | $8.9B |
| — Equity — | |||||
| Common Stock | $12.0B | $12.0B | $12.0B | $12.0B | $12.0B |
| Retained Earnings | $8.0B | $8.4B | $9.4B | $9.5B | $0 |
| Accumulated OCI | -$229M | -$229M | -$243M | -$251M | $0 |
| Total Stockholders Equity | $19.7B | $20.2B | $21.2B | $21.2B | $20.5B |
| Total Liabilities & Equity | $36.4B | $35.6B | $37.1B | $35.1B | $32.4B |
| — Key Metrics — | |||||
| Total Debt | $5.1B | $5.0B | $5.2B | $4.0B | $2.5B |
| Net Debt | $2.2B | $2.0B | $2.1B | $149M | -$1.6B |
| Total Investments | $18M | $15M | $685M | $1.5B | $1.3B |